30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CHAPTER 1 PRINCIPLES OF CLINICAL PHARMACOLOGY<br />

● Barrier to absorptive surfaces. Food may impose a<br />

physical barrier to the dissemination of drugs to<br />

mucosal absorptive surfaces. In addition, some food<br />

constituents (particularly fiber) can be a site of drug<br />

adsorption, effectively reducing the quantity of drug<br />

available for absorption.<br />

● Pharmacologically active food constituents. While<br />

not a usual component of the diet of dogs and cats,<br />

in humans the ingestion of Seville oranges, limes<br />

or grapefruit juice (which all contain biologically<br />

active polyphenolic furanocoumarins) has been<br />

reported to inhibit certain cytochrome P450 isoenzymes<br />

(particularly CYP3A), leading to increased<br />

bioavailability of a number of drugs that otherwise<br />

would have been metabolized. Inhibition of CYP has<br />

also been reported in humans consuming garlic<br />

extracts or St John’s wort.<br />

The magnitude of a food–drug interaction is dependent<br />

on the following factors.<br />

● The physicochemical properties of the drug<br />

– The main considerations include the pKa and<br />

chemical lability of the drug.<br />

– Nonionized forms of drugs are most readily<br />

absorbed and the pH of the milieu in which the<br />

drug is absorbed will determine the relative concentrations<br />

of ionized and nonionized drug.<br />

– Acid-labile drugs may benefit (though unpredictably)<br />

from coadministration with food, as<br />

gastric pH is buffered and elevated to a variable<br />

extent.<br />

● Formulation<br />

– Egress from the stomach is quickest for solutions,<br />

followed by suspensions, pastes, tablets and<br />

capsules.<br />

– It has been observed that particles of diameter up<br />

to 1.6 mm empty more rapidly than the meal,<br />

while particles larger than 2.4 mm empty more<br />

slowly.<br />

– The protective barriers provided by enteric-coated<br />

tablets may be breached and protection from<br />

gastric acid reduced if the dosage form resides for<br />

protracted periods in the stomach.<br />

– Formulations with a density less than unity may<br />

have increased residence in the stomach due to<br />

buoyancy effects. Experimentally, advantage has<br />

been taken of this phenomenon in the design of<br />

sustained-release formulations.<br />

● Type and size of meal<br />

– Liquid and low-viscosity meals are associated<br />

with rapid gastric emptying and may lead to<br />

increased or decreased bioavailability of coadministered<br />

drugs, depending on the time necessary<br />

for disintegration and dissolution of dosage<br />

forms.<br />

– High-fat meals are followed by increased concentrations<br />

of circulating free fatty acids, which<br />

bind to albumin and limit the number of binding<br />

sites available for acidic drugs. This can lead to<br />

increased free drug and more rapid clearance.<br />

Notably, fasting is also associated with increased<br />

concentrations of free fatty acids from the mobilization<br />

of endogenous depots and can lead to the<br />

same effect on drugs.<br />

– In humans, diets high in protein and low in carbohydrate<br />

have been associated with increased<br />

hepatic mixed function oxidase activity, which<br />

led to more rapid clearance of theophylline and<br />

propranolol.<br />

– The bioavailability of a number of drugs (especially<br />

the fluoroquinolones and tetracyclines;<br />

doxycycline is an exception) is adversely affected<br />

by the presence of divalent and trivalent cations,<br />

as may be present in dairy products (Ca 2+ ) and<br />

antacids (Mg 2+ and Al 3+ ). Insoluble complexes are<br />

formed, resulting in reduced absorption. Dietary<br />

milk can elevate gastric pH and accelerate the<br />

dissolution of enteric-coated tablets, leading to<br />

drug release and possible gastric irritation or drug<br />

degradation.<br />

– A number of studies in dogs have demonstrated<br />

a more marked effect on drug availability<br />

of dry food than semi-moist canned food, presumably<br />

because of a more delayed gastric<br />

emptying.<br />

● Time interval and sequence between eating and drug<br />

administration<br />

– While the optimum fasting period will depend on<br />

the animal, the drug and the meal, for those drugs<br />

that may be adversely affected by feeding it is<br />

generally recommended that 1–2 hours should<br />

elapse between feeding (either before or after) and<br />

drug administration.<br />

– A possible exception is that a greater period may<br />

be necessary after feeding when a dry ration is<br />

consumed.<br />

Drug interactions<br />

A drug interaction occurs when the effect of one drug<br />

is changed by the presence of another drug. The interaction<br />

can have positive (e.g. the synergism of coad<br />

ministered amoxicillin and clavulanic acid) or harmful<br />

consequences (as may be associated with the interaction<br />

of potassium-depleting diuretics and digoxin). Many<br />

possible interactions have been described in both medical<br />

and veterinary practice, but a caution has been issued<br />

that the data are widely variable in quality and reliability.<br />

While some interactions have been critically evaluated<br />

under controlled conditions, others ‘are no more<br />

16

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!